We have a new address! Find us here: 4201 Corporate Drive, Suite 100, West Des Moines, Iowa 50266 Click here to view directions:
We provide sponsors with value-added services, such as our highly regarded Protocol Review Service and efficient, niche, and specialized marketing for clinical trials.
Site Strengths
- Experienced research coordinators with a special interest in diabetes
- Experienced investigators with 150+ clinical trials started
- High-quality research performance (FDA audit in 2017 with no findings)
- First ever research-based patient portal
- Multiple community relationships providing referrals for research
- Ability to use a Central IRB
- Clinical trial management software ensuring efficient organization of all research activities
Additional Services to Optimize Clinical Trial Enrollment & Retention
With our passion for transforming diabetes and our experience in 150+ diabetes drug & device trials, we provide several unique solutions to Sponsors to optimize clinical trial enrollment & retention like our Initial Protocol Reviews, Targeted Marketing, Specialized CRA Training, Consultation Services and more!
Protocol Review Service
This service includes a comprehensive evaluation of clinical trial protocols conducted over 4-6 weeks by our multidisciplinary team of experts to address clinical or operational issues, correct errors, or improve recruitment.
Marketing for Sponsors
We offer targeted marketing and lead management to help sponsors find and engage eligible trial participants across the USA. Our digital campaigns and pre-qualification methods streamline recruitment and improve enrollment.
Consultation with Dr. Anuj Bhargava
With 17 years of clinical trial experience through 150+ trials, Dr. Bhargava has a keen interest in driving therapy (drugs & devices) from the market to real-world outcomes and is equally passionate about guiding sponsors for successful trial performance.
CRA & Sponsor Team Member Training/Preceptorship
With real-life, onsite training, we host CRAs or other staff at our center for a two-day workshop and provide them with real-time clinical trial experience.
We are a multi-center site in Central Iowa performing research in diabetes, diabetes-related conditions, and hormonal disorders.
Type 2 Diabetes
Type 1 Diabetes
Pumps, CGMs, Glucose Meters
MASH
Retinopathy
Kidney Disease
Obesity
Men’s Health (Low-T & Erectile Dysfunction)
Cardiovascular Disease
Testimonials
Recruitment History
Iowa Diabetes Research has a strong history of success in trial recruitment, having over-recruited for a
majority of studies we have done to date.
Our Patient
Qualifier platform allows us to efficiently and effectively recruit study participants using
real-time health data and communication features.
Most of our research patients join another study with us after they finish their current study because of
our caring, passionate, and patient-centered staff.
| Company/Medication | Enrollment Goal | Screened | Randomized | % Enrollment |
|---|---|---|---|---|
| Medtronic/Pump use in T1D | 12 | 51 | 41 | 342% |
| GlaxoSmithKline/CV outcomes | 10 | 31 | 28 | 280% |
| Gan and Lee/ Biosimilar insulin glargine in T2D | 12 | 31 | 23 | 192% |
| Lilly/T2DM ultra rapid acting formula insulin lispro | 8 | 24 | 13 | 163% |
| Gan and Lee/ Biosimilar insulin glargine in T1D | 12 | 27 | 19 | 158% |
| Novo Nordisk/GLP-1 use for treatment of obesity | 7 | 16 | 11 | 157% |
| Lilly/T1DM ultra rapid acting formula insulin lispro | 13 | 31 | 19 | 146% |
| Boehringer Ingelheim/SGLT-2 in T1D | 36 | 50 | 48 | 133% |
| Dexcom/CGM use in T1D and T2D | 50 | 59 | 55 | 110% |
Partners We’ve Worked With
